IDSA GUIDELINES Bundle (free trial)

Diagnosis of Tuberculosis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/810888

Contents of this Issue

Navigation

Page 6 of 11

7 ➤ The panel recommends that mycobacterial cultures be performed, rather than not performed, on specimens collected from sites of suspected extrapulmonary TB (S-L). Remarks: A positive result can be used as evidence of extrapulmonary TB and guide decision making because false-positive results are unlikely. However, a negative result may not be used to exclude TB because false-negative results are exceedingly common. ➤ The panel suggests that NAAT be performed, rather than not performed, on specimens collected from sites of suspected extrapulmonary TB (C-VL). Remarks: A positive NAAT result can be used as evidence of extrapulmonary TB and guide decision making because false-positive results are unlikely. However, a negative NAAT result may not be used to exclude TB because false-negative results are exceedingly common. At present, NAAT testing on specimens other than sputum is an off-label use of the test. ➤ The panel suggests that histological examination be performed, rather than not performed, on specimens collected from sites of suspected extrapulmonary TB (C-VL). Remarks: Both positive and negative results should be interpreted in the context of the clinical scenario because neither false-positive nor false-negative results are rare. ➤ The panel recommends a culture isolate from each mycobacterial culture-positive patient be submitted to a regional genotyping laboratory for genotyping (S-VL). Table 1. Essential Laboratory Tests for the Detection of Mtb Test Time Required I. Nucleic acid amplification test detection (NAAT-TB) 1 d II. Nucleic acid amplification test, resistance markers (NAAT-R) 1–2 d III. Acid-fast bacilli microscopy 1 d IV. Growth detection Up to 6–8 wk Liquid (average 10–14 d) Solid (average 3–4 wk) V. Identification of Mtb complex by DNA probe or high- performance liquid chromatography (HPLC). 1 d a VI. First-line drug susceptibility testing (liquid medium) 1–2 wk a VII. Second-line and novel compound drug susceptibility testing Liquid 1–2 wk a Solid 3–4 wk a a Aer detection of growth S, strong ; C, conditional; H, high; M, moderate; L, low; VL, very low quality of evidence

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Diagnosis of Tuberculosis